ARD:2022年美国风湿病学会/欧洲风湿病学会联盟显微镜下多血管炎分类标准

2022-03-13 MedSci原创 MedSci原创

2022 年美国风湿病学会/欧洲风湿病协会联盟 MPA 分类标准现已得到验证,可用于临床研究。

  目的:MPA显微镜下多血管)和 PAN(结节性多动脉炎)之间的主要区别特征是 MPA 中小动脉、小静脉或毛细血管中少免疫血管炎的存在。 PAN是仅限于中血管疾病,MPA 是一种主要是小血管炎,也可以涉及中血管。本文目的是制定和验证显微镜下多血管炎 (MPA) 的分类标准。

   方法:患有血管炎或比较疾病的患者被招募到一个国际队列中。该研究分五个阶段进行:(1)使用共识方法识别候选项目,(2)在诊断时前瞻性收集候选项目,(3)数据驱动减少候选项目的数量,(4)专家小组审查病例以确定参考诊断和 (5) 使用最小绝对收缩和选择运算符逻辑回归在开发集中推导疾病分类的基于分数的风险评分,随后在独立的一组特征案例和比较疾病中验证性能。

    结果:MPA的开发数据集包括149MPA408例比较病例。验证集由另外142 MPA414 例比较病例组成。从91个候选项目中,回归分析确定了10MPA项目,其中6个被保留。最终标准及其权重如下:核周抗中性粒细胞胞浆抗体(ANCA)或抗髓过氧化物酶-ANCA阳性(+6)、少免疫性肾小球肾炎(+3)、肺纤维化或间质性肺病(+3)、sino-鼻部症状或体征 (-3),细胞质ANCA或抗蛋白酶 3 ANCA 阳性 (-1) 和嗜酸性粒细胞计数 1×109/L (-4)。在排除类似血管炎的情况后,诊断为小血管炎或中血管炎的患者可归类为 MPA,累积评分≥5 分。在验证数据集中测试这些标准时,敏感性为 91%95% CI 85% 95%),特异性为 94%95% CI 92% 96%

  结论:2022 年美国风湿病学会/欧洲风湿病协会联盟 MPA 分类标准现已得到验证,可用于临床研究。

 

出处:

Suppiah R, Robson JC, Grayson PC THE DCVAS INVESTIGATORS, et al. 2022 American College of Rheumatology/European Alliance of Associations for Rheumatology classification criteria for microscopic polyangiitis. Annals of the Rheumatic Diseases 2022;81:321-326.

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (9)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-06-02 tulenzi
  4. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
  7. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-14 zexyw04
  8. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
  9. [GetPortalCommentsPageByObjectIdResponse(id=1807439, encodeId=5cec180e439bd, content=<a href='/topic/show?id=9f1be9908f9' target=_blank style='color:#2F92EE;'>#美国风湿病学会#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=29, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=79908, encryptionId=9f1be9908f9, topicName=美国风湿病学会)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=74808, createdName=quxin068, createdTime=Sat Mar 19 09:57:43 CST 2022, time=2022-03-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1744034, encodeId=efcc1e440345e, content=<a href='/topic/show?id=414659e35b4' target=_blank style='color:#2F92EE;'>#显微镜下多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59735, encryptionId=414659e35b4, topicName=显微镜下多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d35535252845, createdName=bnurmamat, createdTime=Wed Jun 01 07:57:43 CST 2022, time=2022-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1893810, encodeId=34d3189381087, content=<a href='/topic/show?id=ab2159e343a' target=_blank style='color:#2F92EE;'>#显微镜#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59734, encryptionId=ab2159e343a, topicName=显微镜)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=54f9127, createdName=tulenzi, createdTime=Thu Jun 02 12:57:43 CST 2022, time=2022-06-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1263273, encodeId=55f212632e384, content=<a href='/topic/show?id=581e8968859' target=_blank style='color:#2F92EE;'>#血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=89688, encryptionId=581e8968859, topicName=血管炎)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=909c71, createdName=shijzhiewnjhch, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1339446, encodeId=29711339446b6, content=<a href='/topic/show?id=447663054f5' target=_blank style='color:#2F92EE;'>#欧洲#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=63054, encryptionId=447663054f5, topicName=欧洲)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/PiajxSqBRaEKxsKDoOOFxGpMibw6lsQFUIicWt7kWGevkdgFhjiban1icD2JdIBmjVo7qX7aSlCSpiaia382nuLKiaI3Cg/132, createdBy=5c442500150, createdName=ms9474365431325850, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1422980, encodeId=948d1422980cd, content=<a href='/topic/show?id=e2c531819ce' target=_blank style='color:#2F92EE;'>#分类标准#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=31819, encryptionId=e2c531819ce, topicName=分类标准)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=94d23750245, createdName=yytms, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1496709, encodeId=70211496e0973, content=<a href='/topic/show?id=bbd780e4884' target=_blank style='color:#2F92EE;'>#联盟#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=80748, encryptionId=bbd780e4884, topicName=联盟)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=d7fc9269968, createdName=zexyw04, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1545900, encodeId=dcc515459009b, content=<a href='/topic/show?id=f5e743450aa' target=_blank style='color:#2F92EE;'>#多血管炎#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=33, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=43450, encryptionId=f5e743450aa, topicName=多血管炎)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0b6013824614, createdName=12498bf3m29暂无昵称, createdTime=Mon Mar 14 22:57:43 CST 2022, time=2022-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1202353, encodeId=0a6c120235384, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a0906550603, createdName=ms4000000653610430, createdTime=Sun Mar 13 23:19:53 CST 2022, time=2022-03-13, status=1, ipAttribution=)]
    2022-03-13 ms4000000653610430

    学习了

    0

相关资讯

ARD:2022 美国风湿病学会/欧洲风湿病学协会联盟嗜酸性肉芽肿伴多血管炎分类标准

2022 年美国风湿病学会/欧洲风湿病学协会联盟嗜酸性肉芽肿伴多血管炎分类标准表现出强大的性能特征,并经验证可用于研究。

ACR 2021——30年了!ACR血管炎标准终于更新了!

目前临床上采用的血管炎分类标准还是1990年的ACR标准。旧标准已经不能够很好的辅助临床的诊疗,血管炎亟待一个新的标准。于今年刚结束的ACR大会上,发布了最新的2022年的血管炎分类标准。

2018年《国际儿童风湿病试验组织(PRINTO)幼年特发性关节炎新分类标准专家共识(启动步骤)》中国专家解读

中国儿童免疫与健康联盟组织了部分中国专家对这一国际共识进行解读,旨在对JIA新分类提出中国专家的建议观点,并为我国以后JIA相关真实世界研究提供依据,为与国际新标准接轨提出中国专家的意见。该文仅进行忠实于英文原文的解读,JIA新的分类标准在我国的形成及运用还需要进一步研究及探讨。

2019年EULAR/ACR系统性红斑狼疮分类标准解读

欧洲抗风湿病联盟(EULAR)和美国风湿病学会(ACR)近日在风湿病年鉴(Ann Rheum Dis)和风湿病与关节炎(Arthritis Rheumatol)杂志上正式发布了最新的系统性红斑狼疮(SLE)分类标准。该标准于2017年提出后经过为期2年的临床验证显示了较高敏感性和特异性。相较于1997年ACR标准和2012年系统性红斑狼疮国际临床协助组(SLICC)分类标准,新标准运用了更加严谨的

2019 EULAR/ACR标准:系统性红斑狼疮的分类标准

2019年9月,欧洲抗风湿病联盟(EULAR)联合美国风湿病学会(ACR)共同发布了系统性红斑狼疮的分类标准,新的分类标准是在多学科和国际方面的投入下,采用严格的方法制定,具有极好的敏感性和特异性。

Arthritis Rheumatol:通过共识方法制定硬皮病肾危象的分类标准

通过共识方法确定了表征SRC的一组核心项目。